• OPEN AN ACCOUNT
Indian Indices
Nifty
25,069.20 -44.80
(-0.18%)
Sensex
82,380.69 594.95
( 0.73%)
Bank Nifty
54,887.85 78.55
( 0.14%)
Nifty IT
35,902.20 -208.55
( -0.58%)
Global Indices
Nasdaq
45,900.55 45.32
(0.10%)
Dow Jones
6,635.85 30.56
(0.46%)
Hang Seng
44,932.94 164.82
(0.37%)
Nikkei 225
9,277.03 -6.26
(-0.07%)
Forex
USD-INR
88.27 0.00
(0.00%)
EUR-INR
103.57 0.18
(0.18%)
GBP-INR
119.65 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Zydus Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532321
INE010B01027
210.5884278
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZYDUSLIFE
23.4
104316.28
EPS(TTM)
Face Value()
Div & Yield %
44.31
1
1.06
 
Particulars(INCOME)Mar 2025
( Cr)
Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Sales Turnover 15116.3010818.708731.607836.907780.006347.40
Excise Duty0.000.000.000.000.000.00
Net Sales15116.3010818.708731.607836.907780.006347.40
Other Income 696.201084.80548.40178.7089.30908.70
Stock Adjustments 121.10131.70-105.1046.90148.30-15.50
Total Income15933.6012035.209174.908062.508017.607240.60
EXPENDITURE :
Raw Materials 3138.003284.603066.202917.102499.701936.20
Power & Fuel Cost286.20298.20278.60245.20193.20208.40
Employee Cost 1762.201507.501321.901204.901147.301077.40
Other Manufacturing Expenses 439.70347.20332.50381.10363.40327.30
Selling & Administrative Expenses 1384.001017.801039.80958.401009.10925.30
Miscellaneous Expenses 491.00445.00336.90578.30594.40486.20
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure7501.106900.306375.906285.005807.104960.80
Operating Profit8432.505134.902799.001777.502210.502279.80
Interest 463.90390.70278.20134.9070.90233.90
Gross Profit7968.604744.202520.801642.602139.602045.90
Depreciation523.90504.40488.60478.70451.10428.90
Profit Before Tax7444.704239.802032.201163.901688.501617.00
Tax1582.50934.30461.80260.20303.30164.10
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax87.30-136.0041.2045.80-91.0040.00
Reported Net Profit5774.903441.501529.20857.901476.201412.90
Extraordinary Items 27.403.90-92.27-237.64-156.95-52.67
Adjusted Net Profit5747.503437.601621.471095.541633.151465.57
Adjustment below Net Profit -26.40-54.001.80-6.90-15.30-6.00
P & L Balance brought forward13347.6010567.409289.408796.907336.006645.70
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 301.90607.30253.00358.500.00716.60
P & L Balance carried down18794.2013347.6010567.409289.408796.907336.00
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1100.00300.00600.00250.00350.00350.00
Dividend Per Share(Rs)11.003.006.002.503.503.50
Earnings Per Share-Unit Curr57.4034.2115.118.3814.4213.80
Earnings Per Share(Adj)-Unit Curr57.4034.2115.118.3814.4213.80
Book Value-Unit Curr210.64156.23134.78129.30124.46109.96
Book Value(Adj)-Unit Curr210.64156.23134.78129.30124.46109.96